BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18303826)

  • 1. Discovery of subnanomolar arginine-glycine-aspartate-based alphaVbeta3/alphaVbeta5 integrin binders embedding 4-aminoproline residues.
    Zanardi F; Burreddu P; Rassu G; Auzzas L; Battistini L; Curti C; Sartori A; Nicastro G; Menchi G; Cini N; Bottoncetti A; Raspanti S; Casiraghi G
    J Med Chem; 2008 Mar; 51(6):1771-82. PubMed ID: 18303826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grafting aminocyclopentane carboxylic acids onto the RGD tripeptide sequence generates low nanomolar alphaVbeta3/alphaVbeta5 integrin dual binders.
    Casiraghi G; Rassu G; Auzzas L; Burreddu P; Gaetani E; Battistini L; Zanardi F; Curti C; Nicastro G; Belvisi L; Motto I; Castorina M; Giannini G; Pisano C
    J Med Chem; 2005 Dec; 48(24):7675-87. PubMed ID: 16302808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of the unusual C(alpha)-fluoroalkylamino acids into cyclopeptides: synthesis of arginine-glycine-aspartate (RGD) analogues and study of their conformational and biological behavior.
    Dal Pozzo A; Ni M; Muzi L; de Castiglione R; Mondelli R; Mazzini S; Penco S; Pisano C; Castorina M; Giannini G
    J Med Chem; 2006 Mar; 49(5):1808-17. PubMed ID: 16509596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Aminoproline-based arginine-glycine-aspartate integrin binders with exposed ligation points: practical in-solution synthesis, conjugation and binding affinity evaluation.
    Battistini L; Burreddu P; Carta P; Rassu G; Auzzas L; Curti C; Zanardi F; Manzoni L; Araldi EM; Scolastico C; Casiraghi G
    Org Biomol Chem; 2009 Dec; 7(23):4924-35. PubMed ID: 19907783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic RGD peptidomimetics containing bifunctional diketopiperazine scaffolds as new potent integrin ligands.
    Marchini M; Mingozzi M; Colombo R; Guzzetti I; Belvisi L; Vasile F; Potenza D; Piarulli U; Arosio D; Gennari C
    Chemistry; 2012 May; 18(20):6195-207. PubMed ID: 22517378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human integrin alphavbeta5: homology modeling and ligand binding.
    Marinelli L; Gottschalk KE; Meyer A; Novellino E; Kessler H
    J Med Chem; 2004 Aug; 47(17):4166-77. PubMed ID: 15293989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin.
    Yokosaki Y; Tanaka K; Higashikawa F; Yamashita K; Eboshida A
    Matrix Biol; 2005 Sep; 24(6):418-27. PubMed ID: 16005200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, SAR and in vitro evaluation of new cyclic Arg-Gly-Asp pseudopentapeptides containing a s-cis peptide bond as integrin alphavbeta3 and alphavbeta5 ligands.
    Salvati M; Cordero FM; Pisaneschi F; Melani F; Gratteri P; Cini N; Bottoncetti A; Brandi A
    Bioorg Med Chem; 2008 Apr; 16(8):4262-71. PubMed ID: 18343671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morpholine-based RGD-cyclopentapeptides as alphavbeta3/alphavbeta5 integrin ligands: role of configuration towards receptor binding affinity.
    Cini N; Trabocchi A; Menchi G; Bottoncetti A; Raspanti S; Pupi A; Guarna A
    Bioorg Med Chem; 2009 Feb; 17(4):1542-9. PubMed ID: 19195898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shifting Towards α
    Bugatti K; Bruno A; Arosio D; Sartori A; Curti C; Augustijn L; Zanardi F; Battistini L
    Chemistry; 2020 Oct; 26(59):13468-13475. PubMed ID: 32634263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel and selective alpha(v)beta3 receptor peptide antagonist: design, synthesis, and biological behavior.
    Del Gatto A; Zaccaro L; Grieco P; Novellino E; Zannetti A; Del Vecchio S; Iommelli F; Salvatore M; Pedone C; Saviano M
    J Med Chem; 2006 Jun; 49(11):3416-20. PubMed ID: 16722662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting integrins: insights into structure and activity of cyclic RGD pentapeptide mimics containing azabicycloalkane amino acids.
    Belvisi L; Bernardi A; Colombo M; Manzoni L; Potenza D; Scolastico C; Giannini G; Marcellini M; Riccioni T; Castorina M; LoGiudice P; Pisano C
    Bioorg Med Chem; 2006 Jan; 14(1):169-80. PubMed ID: 16214345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docking studies on alphavbeta3 integrin ligands: pharmacophore refinement and implications for drug design.
    Marinelli L; Lavecchia A; Gottschalk KE; Novellino E; Kessler H
    J Med Chem; 2003 Oct; 46(21):4393-404. PubMed ID: 14521404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand.
    Xiong JP; Stehle T; Zhang R; Joachimiak A; Frech M; Goodman SL; Arnaout MA
    Science; 2002 Apr; 296(5565):151-5. PubMed ID: 11884718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between biological activity and binding energy in systems of integrin with cyclic RGD-containing binders: a QM/MM molecular dynamics study.
    Xiang M; Lin Y; He G; Chen L; Yang M; Yang S; Mo Y
    J Mol Model; 2012 Nov; 18(11):4917-27. PubMed ID: 22736220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bicyclic RGD Peptides with Exquisite Selectivity for the Integrin α
    Bernhagen D; Jungbluth V; Quilis NG; Dostalek J; White PB; Jalink K; Timmerman P
    ACS Comb Sci; 2019 Mar; 21(3):198-206. PubMed ID: 30624885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Click-chemistry-derived triazole ligands of arginine-glycine-aspartate (RGD) integrins with a broad capacity to inhibit adhesion of melanoma cells and both in vitro and in vivo angiogenesis.
    Trabocchi A; Menchi G; Cini N; Bianchini F; Raspanti S; Bottoncetti A; Pupi A; Calorini L; Guarna A
    J Med Chem; 2010 Oct; 53(19):7119-28. PubMed ID: 20809642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modeling of the thyroid hormone interactions with alpha v beta 3 integrin.
    Cody V; Davis PJ; Davis FB
    Steroids; 2007 Feb; 72(2):165-70. PubMed ID: 17166537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressory activity of the cyclodimeric peptide with RGD-sequences.
    Szewczuk Z; Buczek P; Stefanowicz P; Krajewski K; Wieczorek Z; Siemion IZ
    Acta Biochim Pol; 2001; 48(1):121-30. PubMed ID: 11440161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photocontrol of cell adhesion processes: model studies with cyclic azobenzene-RGD peptides.
    Schütt M; Krupka SS; Milbradt AG; Deindl S; Sinner EK; Oesterhelt D; Renner C; Moroder L
    Chem Biol; 2003 Jun; 10(6):487-90. PubMed ID: 12837381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.